Dataset from A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-56418 Sodium in Subjects With Endometriosis

Name: Dataset from A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-56418 Sodium in Subjects With Endometriosis
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-05-02 收录

下载链接：

https://doi.org/10.25934/00005300

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study is to evaluate elagolix (NBI-56418) compared to placebo for its effects on endometriosis related pelvic pain and its safety.

创建时间：

2024-11-26